论文部分内容阅读
血源性乙肝疫苗能有效预防乙型病毒性肝炎的发生，已被大量研究证实。但是，由于血源供应紧张和血液传播疾病增多等原因，使血源性乙肝疫苗正逐渐被基因重组疫苗所替代。国外许多报道认为，乙肝基因重组疫苗与血源性疫苗在安全性和免疫源性等方面没有显著的区别。而我国乙肝基
Hematological hepatitis B vaccine can effectively prevent the occurrence of hepatitis B virus has been confirmed by a large number of studies. However, because of the shortage of blood supply and the increase of blood-borne diseases, the blood-borne hepatitis B vaccine is being gradually replaced by the recombinant DNA vaccine. Many foreign reports that the hepatitis B gene recombinant vaccine and blood-borne vaccine in terms of safety and immunogenicity, there is no significant difference. And our hepatitis B base